Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
nChroma Bio sheds staff in research reorganization
Formed from a merger in December 2024, nChroma is laying off staff and deprioritizing the research spearheaded by one of its parent companies.
Darren Incorvaia
Nov 12, 2025 5:31pm
FDA unveils new pathway to speed custom gene editing therapies
Nov 12, 2025 5:00pm
Fierce Pharma
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
Nov 12, 2025 11:36am
Metagenomi sheds 25% of workforce, including CEO
Nov 12, 2025 6:30am
Lyell signs deal for phase 1-stage colorectal cancer CAR-T
Nov 10, 2025 9:45am
Lilly bags eye-catching gene therapy in $475M deal
Nov 10, 2025 7:00am
